Article
Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.
European journal of preventive cardiology - 1 Jul 2018
Buonuomo Paola S, Macchiaiolo Marina, Leone Giovanna, Valente Paola, Mastrogiorgio Gerarda, Gnazzo Maria, Rana Ippolita, Gonfiantini Michaela V, Gagliardi Maria G, Romano Francesca, Bartuli Andrea
Abstract excerpt
Background Homozygous familial hypercholesterolaemia is a rare life-threatening disease characterized by markedly elevated low-density lipoprotein cholesterol (LDL-C) concentrations and accelerated atherosclerosis. The presence of double gene defects in the LDL-Receptor, either the same defect (homozygous) or two different LDL-raising mutations (compound heterozygotes) or other variants, identify the homozygous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
